| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Prin. Fin. And Acctg. Officer | Interim Cfo/ Cao/ VP Of Finance | CAO And VP Of Finance +1 more
1 company
Donegan Michael C serves as a Prin. Fin. And Acctg. Officer at TXMD. Across recent SEC filings that breaks down to 0 buys and 7 sells.
Historically, Donegan Michael C's trades have earned a strong insider score of 85/100 across 7 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +65.6%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 27, 2023 | TXMD Therapeuticsmd, Inc. | Prin. Fin. And Acctg. Officer | Sale+OE | 1,697 | $5.08 | $8,620.59 | -12.5% | -32.0% | -57.5% | |
| Jan 24, 2023 | TXMD Therapeuticsmd, Inc. | Prin. Fin. And Acctg. Officer | Sale+OE | 1,309 | $5.34 | $6,987.64 | -14.7% | -29.4% | -56.3% | |
| Dec 6, 2022 | TXMD Therapeuticsmd, Inc. | Interim Cfo/ Cao/ VP Of Finance | Sale+OE | 910 | $4.78 | $4,345.25 | -16.7% | -12.0% | -58.4% | |
| Nov 30, 2021 | TXMD Therapeuticsmd, Inc. | CAO And VP Of Finance | Sale+OE | 29,790 | $0.54 | $15,946.59 | -23.1% | -51.7% | -81.5% | |
| May 11, 2021 | TXMD Therapeuticsmd, Inc. | CAO And VP Finance | Sale+OE | 4,842 | $1.04 | $5,035.68 | -25.5% | -8.4% | -93.3% |